Renalytix plc Quarterly Share-based Payment Arrangement, Expense in USD from Q4 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Renalytix plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q4 2020 to Q1 2024.
  • Renalytix plc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $385K, a 50% decline year-over-year.
  • Renalytix plc Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $1.88M, a 54.7% decline year-over-year.
  • Renalytix plc annual Share-based Payment Arrangement, Expense for 2023 was $2.94M, a 36.5% decline from 2022.
  • Renalytix plc annual Share-based Payment Arrangement, Expense for 2022 was $4.62M, a 78.7% increase from 2021.
  • Renalytix plc annual Share-based Payment Arrangement, Expense for 2021 was $2.59M, a 123% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.88M $385K -$385K -50% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.27M $385K -$430K -52.8% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $2.7M $524K -$239K -31.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.94M $588K -$1.22M -67.5% Apr 1, 2023 Jun 30, 2023 10-K 2023-09-28
Q1 2023 $4.16M $770K -$153K -16.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $4.31M $815K -$98K -10.7% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 $4.41M $763K -$211K -21.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $4.62M $1.81M Apr 1, 2022 Jun 30, 2022 10-K 2023-09-28
Q1 2022 $923K +$922K +150964% Jan 1, 2022 Mar 31, 2022 6-K 2023-06-09
Q4 2021 $913K +$411K +81.9% Oct 1, 2021 Dec 31, 2021 6-K 2023-03-30
Q3 2021 $974K Jul 1, 2021 Sep 30, 2021 6-K 2022-11-30
Q1 2021 $611* Jan 1, 2021 Mar 31, 2021 6-K 2022-06-30
Q4 2020 $502K Oct 1, 2020 Dec 31, 2020 6-K/A 2022-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.